Today: 8 February 2026
Subscribe

Sea Limited (SE) Stock: Q3 2025 Earnings, $1 Billion Buyback and 2026 Price Targets Explained

Sea Limited (SE) Stock: Q3 2025 Earnings, $1 Billion Buyback and 2026 Price Targets Explained

Sea Limited’s stock has had a whiplash year. After soaring earlier in 2025, the shares have pulled back sharply following third‑quarter earnings, even as the company delivered some of its strongest growth metrics in years and announced a $1 billion share repurchase program. As of intraday trading on December 9, 2025, Sea Limited (NYSE: SE) is changing hands around $128 per share, down about 4% on the day and roughly a third below its 52‑week high near $199.dcfmodeling.com The question now dominating investor conversations: is this a buying opportunity, or a warning sign that expectations have run too far ahead
9 December 2025
··
Warner Bros. Discovery (WBD) Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery (WBD) Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery, Inc. (NASDAQ: WBD) is trading like a Hollywood cliffhanger on Tuesday, December 9, 2025. Shares are changing hands around the mid‑$27 range after jumping more than 4% intraday, extending a rally that has seen the stock climb roughly 140–150% over the past year. Smartkarma The catalyst: Paramount Skydance’s surprise all‑cash hostile bid of $30 per share, valuing Warner Bros. Discovery at about $108.4 billion including debt and directly challenging Netflix’s already‑signed $72 billion cash‑and‑stock agreement for WBD’s studios and streaming operations. Reuters+2PR Newswire+2 Below is a detailed look at the latest news, the takeover mechanics, analyst forecasts,
9 December 2025
·
Altimmune (ALT) Stock: CEO Shake-Up, Imminent MASH Data and 250% Upside Forecasts as of December 9, 2025

Altimmune (ALT) Stock: CEO Shake-Up, Imminent MASH Data and 250% Upside Forecasts as of December 9, 2025

Altimmune, Inc. (NASDAQ: ALT) has become a tightly wound biotech story heading into year‑end 2025. The small‑cap developer of liver and metabolic drugs is changing its CEO just weeks before a pivotal 48‑week readout in its lead MASH trial, while Wall Street models still point to triple‑digit upside from today’s share price. As of mid‑day on December 9, 2025, Altimmune stock trades around $5.61 per share, implying a market capitalization of roughly $550 million. Stock Titan That price sits well above its autumn lows but far below analyst targets that cluster in the mid‑teens to high teens. Below is a
9 December 2025
·
Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

As Cemtrex, Inc. (NASDAQ: CETX) heads into trading on Tuesday, December 9, 2025, the tiny tech stock is coming off one of the wildest sessions on the Nasdaq. On Monday, December 8, Cemtrex shares closed at $7.05, up 129.64% from Friday’s close of $3.07, after trading in an extraordinary intraday range of $4.84 to $9.70. StockAnalysis+2StockInvest+2Pre‑market quotes early Tuesday show the stock giving back part of that move, trading around the low‑$6 area (roughly –14% versus Monday’s close), but still far above last week’s levels. StockAnalysis+1 Despite the eye‑popping rally, Cemtrex remains a micro‑cap: its market value sits around $5
9 December 2025
··
Sezzle Inc (SEZL) Stock Outlook: S&P SmallCap 600 Inclusion, Earnings Surge and Price Forecast

Sezzle Inc (SEZL) Stock Outlook: S&P SmallCap 600 Inclusion, Earnings Surge and Price Forecast

Data and news current as of 9 December 2025. This article is for informational purposes only and is not financial advice. Sezzle stock in December 2025: from hyper-growth to “serious contender” Sezzle Inc (NASDAQ: SEZL), the buy-now-pay-later (BNPL) fintech once written off as a niche player, has turned into one of 2025’s wildest rides on the Nasdaq. After a run that saw the stock up around 1,000% over the past year at one point, followed by drawdowns of 40%–70% from its peak, Sezzle has settled—for now—into the role of highly volatile, profitable growth stock with real earnings and real scrutiny.
9 December 2025
··
‘Superflu’ H3N2 K-Strain: Symptoms, Vaccine Protection and How the New Flu Variant Is Hitting Hospitals This Winter

‘Superflu’ H3N2 K-Strain: Symptoms, Vaccine Protection and How the New Flu Variant Is Hitting Hospitals This Winter

Published: 9 December 2025 A heavily mutated flu strain — A/H3N2 subclade K, often dubbed the “K-strain” or “superflu” — is now dominating the 2025–26 flu season and driving record levels of illness in parts of the UK and beyond. On Tuesday, new analysis showed that this K-strain now accounts for around 90% of flu samples in the UK and Japanand has been detected on every continent.The Independent+1 At the same time, NHS leaders in London warn of the “biggest flu wave ever” in the capital, with hospital flu admissions tripling compared with this time last year and “no peak yet in sight”.The Standard Yet there is some good news: early
9 December 2025
UK Stock Market Movers Today (9 December 2025): Most‑Active FTSE 100 Stocks and What’s Driving Them

UK Stock Market Movers Today (9 December 2025): Most‑Active FTSE 100 Stocks and What’s Driving Them

The UK stock market spent Tuesday 9 December 2025 in a holding pattern, with the FTSE 100 drifting around 9,650 points and ending effectively flat, as traders waited for a key US Federal Reserve decision and next week’s Bank of England meeting. Reuters Beneath the calm index level, trading activity was intense in a familiar set of big‑name stocks: banks, energy giants, consumer staples, telecoms and tobacco. According to the London Stock Exchange and live dealing platforms, volume was concentrated in Lloyds, Legal & General, Glencore, Vodafone, Barclays, Tesco, BP, BT, Rolls‑Royce, Magnum Ice Cream and British American Tobacco, among others. Hargreaves Lansdown This article
9 December 2025
··
UK Stock Market Top Losers Today (9 December 2025): BAT Leads FTSE 100 Fallers as Unilever Hangover Lingers

UK Stock Market Top Losers Today (9 December 2025): BAT Leads FTSE 100 Fallers as Unilever Hangover Lingers

The UK stock market spent Tuesday, 9 December 2025, in a cautious mood, with a handful of big names doing most of the damage. The FTSE 100 slipped around 0.1% to roughly 9,640, its lowest close in about two weeks, as investors positioned for a crucial Federal Reserve decision and another Bank of England rate call. TradingView+1 While the index is still hovering near record highs for 2025, British American Tobacco, Chemring and Ashtead were among the standout losers today, and Monday’s sharp falls in Unilever, Barratt Redrow, JD Sports Fashion, Persimmon and Entain are still shaping sentiment. TechStock²+1 Market snapshot: Cautious FTSE 100, weak consumers Two
9 December 2025
··
UK Stock Market Today: Unilever, WPP, Babcock, Trustpilot and Ocado Lead Top Gainers on 9 December 2025

UK Stock Market Today: Unilever, WPP, Babcock, Trustpilot and Ocado Lead Top Gainers on 9 December 2025

The UK stock market nudged higher on Tuesday 9 December 2025, but beneath the calm headline numbers there were some dramatic individual moves – led by a double‑digit jump in Unilever and sharp gains in WPP, defence contractor Babcock, and mid‑cap names such as Trustpilot, Ocado, Helios Towers, Man Group and Moonpig. The FTSE 100 closed fractionally up at 9,653.19 (+0.08%), while the FTSE 250 added 0.17% to 21,957.79, both indices finishing in positive territory after a cautious session. European markets more broadly were also slightly higher, with investors focused on the US Federal Reserve’s two‑day policy meeting that begins later today.
9 December 2025
·
Structure Therapeutics (NASDAQ: GPCR) Stock Explodes on Obesity Pill Data and $500M Offering: Latest News and Forecasts as of December 9, 2025

Structure Therapeutics (NASDAQ: GPCR) Stock Explodes on Obesity Pill Data and $500M Offering: Latest News and Forecasts as of December 9, 2025

Snapshot: Where Structure Therapeutics Stock Stands Today Structure Therapeutics Inc. (NASDAQ: GPCR) has suddenly moved from niche obesity biotech to front‑page market story. As of December 9, 2025, GPCR is trading around $69.98, up roughly 102% in a single session compared with its previous close near $34.56. The stock’s intraday range on December 8 ran from $44.74 to $94.90, marking a new 52‑week high, and lifting its market capitalization to about $4.25 billion.StockAnalysis+1 This explosive move followed positive Phase 2b trial data for the company’s oral GLP‑1 obesity drug aleniglipron and the announcement of a proposed $500 million public offering
9 December 2025
··
Celsius Holdings (CELH) Stock on December 9, 2025: Q3 Earnings, Buyback, Innovation Push and 2026 Forecast

Celsius Holdings (CELH) Stock on December 9, 2025: Q3 Earnings, Buyback, Innovation Push and 2026 Forecast

Celsius Holdings, Inc. (NASDAQ: CELH) is back in the spotlight. After a violent post‑earnings sell‑off in November, the energy‑drink disruptor has stabilized around the mid‑$40s, while fundamentals continue to show triple‑digit revenue growth, expanding gross margins, and a rapidly evolving brand portfolio that now includes Alani Nu and Rockstar Energy.ir.celsiusholdingsinc.com+1 As of the morning of December 9, 2025, CELH trades near $44–45 per share, well below its 52‑week high but still up strongly year to date, and Wall Street’s average 12‑month price targets imply roughly 40–42% upside from here.StockAnalysis+1 This article summarizes the latest news, forecasts, and analysis on Celsius
9 December 2025
·
Creative Media & Community Trust (CMCT) Stock in December 2025: Microcap REIT, Wild Volatility and Bearish Forecasts

Creative Media & Community Trust (CMCT) Stock in December 2025: Microcap REIT, Wild Volatility and Bearish Forecasts

Creative Media & Community Trust Corporation (NASDAQ: CMCT) has turned into one of the more chaotic tickers in the real-estate investment trust (REIT) space as of December 9, 2025. A tiny market cap, massive daily swings, heavy short interest and a high‑profile business pivot have put CMCT squarely on the radar of speculative traders — while most fundamental and quantitative analysts remain firmly skeptical. Below is a structured look at the latest CMCT stock price action, fundamentals, strategic moves and forecasts as of December 9, 2025. CMCT Stock Price Action in Early December 2025 CMCT has behaved less like a
9 December 2025
·
Cheer Holding (CHR) Stock: Buyout Bids, Nasdaq Delisting Risk and Wild Penny-Stock Volatility as of December 9, 2025

Cheer Holding (CHR) Stock: Buyout Bids, Nasdaq Delisting Risk and Wild Penny-Stock Volatility as of December 9, 2025

Cheer Holding, Inc. (NASDAQ: CHR) has become one of the most dramatic micro-cap stories on the Nasdaq in late 2025. The Beijing-based AI and mobile internet company is simultaneously: For traders and investors tracking CHR on December 9, 2025, this is a classic “event-driven penny stock” story where corporate actions and listing status matter as much as fundamentals. Below is a structured look at the latest price action, news, forecasts and risks. Cheer Holding Stock Today: A Five-Cent, Micro-Cap Rollercoaster As of December 9, 2025, Cheer Holding’s Class A shares trade on Nasdaq under the ticker CHR at roughly $0.048–$0.05
9 December 2025
AMD Stock on December 9, 2025: AI Supercomputers, OpenAI Deal and Wall Street Targets in Focus

AMD Stock on December 9, 2025: AI Supercomputers, OpenAI Deal and Wall Street Targets in Focus

Advanced Micro Devices, Inc. (NASDAQ: AMD) remains one of the most closely watched AI and semiconductor names heading into year‑end 2025. The stock is trading around $221 per share in Tuesday’s session, up roughly 190% from its 52‑week low of $76.48 and about 17% below its high near $267, leaving investors debating whether the next big move is higher or lower. MarketBeat Behind the volatile chart is a company leaning hard into data‑center AI, rolling out new accelerators, signing multi‑gigawatt GPU deals, and setting aggressive long‑term earnings targets through 2030. Here’s a detailed look at where AMD stock stands as
9 December 2025
···
Ethereum Price Today: 6.5% Rebound, BlackRock ETF Filing and Binance ‘Market Reset’ as Whales Defend $3K

Ethereum Price Today: 6.5% Rebound, BlackRock ETF Filing and Binance ‘Market Reset’ as Whales Defend $3K

On December 9, 2025, Ethereum (ETH) is trading just above the $3,100–$3,150 zone, extending a sharp 6.5% rebound off this weekend’s lows near $2,945. Nasdaq+1 That bounce comes against a cautious macro backdrop — global equities are soft ahead of a key Federal Reserve decision — yet Ether is outperforming many risk assets and reclaiming key short‑term levels. Investing.com+1 Under the surface, however, derivatives data from Binance and other venues show a market that has been “reset” rather than fully revived: open interest is elevated but stable, leverage has been flushed out since November, and whales are quietly adding exposure
9 December 2025
···
Procter & Gamble (PG) Stock Hits Two‑Year Low as CFO Sounds Alarm on U.S. Consumer – What It Means for Investors Now

Procter & Gamble (PG) Stock Hits Two‑Year Low as CFO Sounds Alarm on U.S. Consumer – What It Means for Investors Now

Procter & Gamble, one of the world’s most defensive blue‑chip stocks, is suddenly trading like a cyclical name. As of December 9, 2025, shares of The Procter & Gamble Company (NYSE: PG) have slid to around $138 in intraday trading, roughly 23% below their 52‑week high near $180 and hovering just above a fresh 52‑week low.StockAnalysis That slump comes despite solid earnings, an upgraded long‑term cash‑return plan, and a dividend track record that would make most CFOs weep with envy. The pressure is coming from somewhere else: a visibly nervous U.S. consumer, tariff headwinds, and growing questions about how much
9 December 2025
·
Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know

Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know

As of December 9, 2025 Exicure, Inc. (NASDAQ: XCUR) has suddenly moved from obscure micro‑cap to front‑page biotech story. After the company reported positive topline Phase 2 data for its lead drug candidate burixafor in multiple myeloma at the 2025 ASH Annual Meeting on December 8, the stock exploded higher in after‑hours and pre‑market trading.Exicure+2Investing.com+2 Below is a comprehensive look at the latest trial results, recent financials, analyst and algorithmic forecasts, and the key risks around Exicure stock as of December 9, 2025. Exicure (XCUR) Stock Today: Price, Volume and Recent Performance Exicure shares have been extraordinarily volatile going into
9 December 2025
··
Biggest Stock Gainers Today in the US (Dec. 9, 2025): Wave Life Sciences, Structure Therapeutics, Confluent and More

Biggest Stock Gainers Today in the US (Dec. 9, 2025): Wave Life Sciences, Structure Therapeutics, Confluent and More

As Wall Street wakes up on Tuesday, December 9, 2025, investors are still digesting a wild Monday session in which a handful of biotech and tech names exploded higher, even as the major indices finished in the red ahead of tomorrow’s pivotal Federal Reserve decision.Reuters+ 1 Because today’s regular trading session has only just begun, “today’s biggest gainers” in practice means the largest movers from Monday’s US session (Dec. 8) that are driving market conversation and premarket positioning on Dec. 9 . Below is a news-style roundup of those stocks, the catalysts behind the rallies, and what Wall Street is
9 December 2025
····
Redmi Note 15 India Launch on January 6, 2026: 108MP Master Pixel Edition, Expected Specs and Price

Redmi Note 15 India Launch on January 6, 2026: 108MP Master Pixel Edition, Expected Specs and Price

The Redmi Note 15 series is finally gearing up for its India debut, and December 9, 2025 has turned into a big news day for Xiaomi fans. Multiple reports and official teasers now confirm that the Redmi Note 15 5G — including a special 108MP “Master Pixel” Edition — will launch in India on January 6, 2026, with Pro and Pro Plus siblings expected to follow soon after. Gadgets 360+2Gizmochina+2 Below is everything that’s been reported today about the Redmi Note 15 India launch date, specifications, design, and expected price, based on official teasers and fresh leaks. India launch date finally confirmed Until now, the
9 December 2025
·
Most Active Stocks Today (December 9, 2025): Nvidia, Tesla, Wave Life Sciences and Confluent Lead a Fed-Focused Wall Street

Most Active Stocks Today (December 9, 2025): Nvidia, Tesla, Wave Life Sciences and Confluent Lead a Fed-Focused Wall Street

New York — December 9, 2025 US investors are crowding into a tight cluster of high-conviction themes today: artificial intelligence chips, blockbuster media and software deals, obesity drugs, and speculative AI small caps. Coming into Tuesday’s session (December 9), Wall Street is just off record highs. On Monday, the S&P 500 slipped about 0.3%, the Dow Jones Industrial Average fell roughly 0.4%, and the tech-heavy Nasdaq eased 0.1%, but all three remained within striking distance of their all-time peaks.The Times Leader+ 1 At the same time, traders are bracing for the Federal Reserve’s final policy decision of 2025, widely expected
9 December 2025
····
1 … 1,042 1,043 1,044 1,045 1,046 … 1,639

Stock Market Today

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 08.02.2026

8 February 2026
LIVEMarkets rolling coverageStarted: February 8, 2026, 12:00 AM ESTUpdated: February 8, 2026, 12:54 AM EST Australian Shares Set for Volatile Earnings Season Amid Market Sensitivity February 8, 2026, 12:49 AM EST. **Australian stock markets** face heightened volatility as earnings season kicks off with little room for error. Analysts warn that even a **1% earnings miss** could trigger sharp price swings, stripping away previous insulation from market shocks. This turbulence reflects the removal of 'shock absorbers' in share prices, signaling an unpredictable three weeks ahead for investors. Anthony Macdonald, business journalist and Chanticleer columnist, forecasts significant fluctuations likely exceeding historical norms.
Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop